MYC and neoplasm: However, 1 prominent exception was apparent: 7 out of the 11 (64%) RMC-7977-resistant tumours exhibited focal copy number gains in Myc, an oncogenic transcription factor that receives mitogenic signals from the RAS pathway (Fig. 6b).